T1	CHEM 61 104	vacuna antigripal tetravalente recombinante
T2	CHEM 106 110	RIV4
T3	CHEM 134 180	vacuna antigripal tetravalente a base de huevo
T4	CHEM 182 186	IIV4
T5	LIVB 191 204	participantes
T6	Age 205 218	de 3 a 8 años
T7	CHEM 276 319	vacuna antigripal tetravalente recombinante
T8	CHEM 342 372	vacuna antigripal tetravalente
T9	Dose 376 390	dosis estándar
T10	CHEM 401 406	huevo
T11	LIVB 410 415	niños
#1	AnnotatorNotes T11	C0008059; Child; Age Group | C0870221; Boys; Age Group
T12	Age 410 415	niños
T13	Age 416 429	de 3 a 8 años
T14	DISO 454 459	Gripe
#2	AnnotatorNotes T14	C0021400; Influenza; Disease or Syndrome
T15	Age 520 533	de 3 a 8 años
T16	LIVB 565 577	participante
T17	LIVB 677 682	padre
#3	AnnotatorNotes T17	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T18	LIVB 686 691	madre
#4	AnnotatorNotes T18	C0026591; Mother (person); Family Group
T19	LIVB 699 718	representante legal
T20	LIVB 724 731	testigo
#5	AnnotatorNotes T20	C0009932; Control Groups; Group | C0682356; Witnesses; Population Group
T21	PROC 783 807	consentimiento informado
#6	AnnotatorNotes T21	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T22	Neg_cue 886 897	Se excluirá
T23	LIVB 916 929	participantes
T24	Negated 916 929	participantes
T25	DISO 980 1019	Inmunodeficiencia congénita o adquirida
T26	Spec_cue 1032 1042	sospechada
T27	PROC 1059 1084	terapias inmunosupresoras
#7	AnnotatorNotes T27	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T28	PROC 1091 1104	quimioterapia
#8	AnnotatorNotes T28	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T29	PROC 1107 1133	radioterapia anticancerosa
T30	Duration 1138 1157	los últimos 6 meses
T31	PROC 1161 1195	terapia con corticoides sistémicos
T32	Date 1196 1210	de largo plazo
T33	CHEM 1212 1222	prednisona
#9	AnnotatorNotes T33	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T34	Duration 1245 1274	más de 2 semanas consecutivas
T35	Duration 1278 1300	los 3 meses anteriores
T36	DISO 1307 1334	Hipersensibilidad sistémica
T37	CHEM 1382 1388	vacuna
#10	AnnotatorNotes T37	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T38	DISO 1407 1417	reacciones
#11	AnnotatorNotes T38	C0221736; Reaction emotional; Finding
T39	PROC 1452 1466	administración
#12	AnnotatorNotes T39	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T40	CHEM 1474 1481	vacunas
#13	AnnotatorNotes T40	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T41	CHEM 1515 1521	vacuna
#14	AnnotatorNotes T41	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T42	DISO 1576 1591	Trombocitopenia
#15	AnnotatorNotes T42	C0040034; Thrombocytopenia; Disease or Syndrome
T43	DISO 1596 1619	Trastornos hemorrágicos
#16	AnnotatorNotes T43	C0019087; Hemorrhagic Disorders; Disease or Syndrome
T44	PROC 1622 1636	administración
#17	AnnotatorNotes T44	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T45	CHEM 1640 1655	anticoagulantes
#18	AnnotatorNotes T45	C0003280; Anticoagulants; Pharmacologic Substance
T46	Duration 1659 1672	las 3 semanas
T47	PROC 1737 1761	vacunación intramuscular
T48	Route 1748 1761	intramuscular
T49	LIVB 1784 1796	investigador
#19	AnnotatorNotes T49	C0035173; Research Personnel; Professional or Occupational Group
T50	DISO 1841 1867	síndrome de Guillain-Barré
#20	AnnotatorNotes T50	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T51	DISO 1869 1872	GBS
#21	AnnotatorNotes T51	C0018378; Guillain-Barre Syndrome; Disease or Syndrome
T52	DISO 1905 1954	retraso clínicamente significativo del desarrollo
T53	LIVB 1969 1981	investigador
#22	AnnotatorNotes T53	C0035173; Research Personnel; Professional or Occupational Group
T54	DISO 1987 2008	trastorno neurológico
#23	AnnotatorNotes T54	C0027765; nervous system disorder; Disease or Syndrome
T55	DISO 2014 2034	trastorno convulsivo
#24	AnnotatorNotes T55	C0014544; Epilepsy; Disease or Syndrome | C0234972; Convulsive disorder; Disease or Syndrome
T56	Neg_cue 2043 2045	no
T57	Negated 2097 2126	todos los aspectos relevantes
T58	Spec_cue 2135 2142	posible
T59	Speculated 2143 2156	participación
T60	LIVB 2163 2171	paciente
#25	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	PROC 2178 2193	estudio clínico
#26	AnnotatorNotes T61	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T62	Speculated 980 1019	Inmunodeficiencia congénita o adquirida
T63	Contraindicated 1737 1761	vacunación intramuscular
T64	Route 1185 1195	sistémicos
T65	CONC 547 556	inclusión
T66	Observation 609 621	asentimiento
T67	Observation 1422 1447	pongan en peligro la vida
T68	CONC 1689 1698	inclusión
T69	Quantifier_or_Qualifier 1913 1939	clínicamente significativo
T70	Quantifier_or_Qualifier 2051 2059	previsto
T71	Observation 2143 2171	participación de un paciente
T72	Patient 191 204	participantes
T73	Patient 410 415	niños
T74	Patient 565 577	participante
T75	Family_member 677 683	padre/
T76	Family_member 686 691	madre
T77	Other 699 718	representante legal
T78	Other 724 731	testigo
T79	Patient 916 929	participantes
T80	History_of 980 1019	Inmunodeficiencia congénita o adquirida
T81	History_of 1059 1084	terapias inmunosupresoras
T82	History_of 1091 1104	quimioterapia
T83	History_of 1107 1133	radioterapia anticancerosa
T84	History_of 1161 1184	terapia con corticoides
T85	History_of 1307 1334	Hipersensibilidad sistémica
T86	History_of 1407 1417	reacciones
T87	Other 1784 1796	investigador
T88	History_of 1905 1912	retraso
T89	History_of 1940 1954	del desarrollo
T90	Other 1969 1981	investigador
T91	History_of 1987 2008	trastorno neurológico
T92	History_of 2014 2034	trastorno convulsivo
T93	Future 2067 2078	información
T94	Patient 2163 2171	paciente
T95	Future 2186 2193	clínico
